EPN's mission is to facilitate the development of compassionate, just, and sustainable health care in and through church healthcare systems.

Welcome to the EPN website!

Our aim is to provide all that you need to know about us and our work, but more than that we hope to provide an information portal for those working in church health services and faith-based drug supply organizations. In order to provide an effective portal we need you, our readers, to become involved in a two-way relationship with us. See below for the latest news.

Revealing the hidden pandemic of antimicrobial resistance

While much attention of the World Health Assembly was given to Influenza A/H1N1, a worried microbiologist from Makerere University Uganda, presented the most shocking data on the consequences of the ongoing pandemic of Antimicrobial Resistance (AMR). Almost half (28 of 62) of patients could not be treated with available antibiotics due to resistance against these
medicines – 86% of these patients were newborns.“A significant number of these babies died” says Dr Florence Najjuka. “10 years ago these lives could have been saved, but today the remaining treatment options are way too costly for most parents.”
read more | 1 attachment

EPN AND ReAct LAUNCH ANTIMICROBIAL RESISTANCE (AMR) CAMPAIGN

Ecumenical Pharmaceutical Network (EPN) and ReAct announce the launch of the Antimicrobial Resistance (AMR) campaign: Fight AMR! Save medicines for our children.

read more

Fight AMR! Save medicines for our children

Submitted by epnuser on Thu, 05/03/2009 - 2:24pm.

epnuser's blog | 3 comments | read more | 4 attachments

Important information

The latest additions to the EPN website include:

In your opinion, what is the greatest cause of antimicrobial resistance(AMR)/Medicine Resistance?

Submitted by epnuser on Fri, 05/06/2009 - 4:08pm.






EPN News

The latest information on EPN activities is available via Netlink, the newsletter for EPN members.

You can also keep up-to-date with pharmaceutical issues affecting resource-poor environments, with the e-Pharmalink newsletter.